Menu

Ian A. Nussbaum

Partner

inussbaum@cooley.com

full contact info

Ian focuses on mergers, acquisitions, divestitures, joint ventures, shareholder activism, corporate governance, takeover defense strategies and related matters. He has advised a range of public and private companies and investors across multiple industries, including technology, life sciences, financial institutions, consumer, gaming and leisure, and industrials.

Download full bio 

Experience

  • Sunrun to Acquire Vivint Solar for Enterprise Value of $3.2 Billion 

  • Portola Agrees to Sell to Alexion for $1.41 Billion 

  • Thirty Madison to Combine With Nurx to Create One Virtual Specialty Care Platform 

  • Five Prime Therapeutics Agrees to Sell to Amgen for $1.9 Billion 

  • Tableau Enters Agreement to Sell to Salesforce for $15.7 Billion 

  • View all

Practices & Industries
Education

  • University of Pennsylvania Law School
    JD, magna cum laude, 2012

  • Columbia University
    BA, magna cum laude, 2007

Admissions & Credentials

New York

California

Media & Insight
Memberships

  • University of Pennsylvania Law School Institute for Law & Economics – Board of advisors

Recent Blog Postings

Delaware Advance Notice Decisions Highlight Move Toward Enhanced Scrutiny of Board Actions, Even Where Conflicts Exist

ESG and M&A: Vetting a Target’s ESG Strengths and Weaknesses to Assess Value, Go-Forward Risks and Disclosure Requirements

Delaware (Again!) Requires Upward Adjustment to Deal Price in Appraisal Proceeding Despite Objectively Fair Sales Process

Cooley’s 2021 Life Sciences M&A Year in Review

Cooley’s 2021 Tech M&A Year in Review

Pleading Bad Faith Against Special Committee Members: A New Trend?

Renegotiating Deal Terms? Delaware Reminds Fiduciaries of Unremitting Duties

Social Distancing From a (Supposed) Life Partner: Early Lessons From Deals Terminated and On the Rocks in the COVID-19 Era

Long-Term Focus: Preparing for Activism + Takeovers Amid COVID-19 Risks

Cooley’s 2019 Tech M&A Year in Review

Cooley's 2019 Life Sciences M&A Year in Review

Taking a Play out of the Financial Acquirer’s Playbook

Use of Earn-Outs to “Bridge” the Valuation Gap

 

 

Contact

inussbaum@cooley.com

+1 212 479 6781

Locations